Olney, United Kingdom

David J Best

This inventor holds 1 USPTO granted patent. Top assignee: Medisense, Inc.. Active years: 1991.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David J Best. Retrieved from https://idiyas.com/inventor/david-j-best-6hmkvmyr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 1991

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David J Best - Innovator in Biotechnological Advancements

Introduction

David J Best is a notable inventor based in Olney, GB. He has made significant contributions to the field of biotechnology, particularly through his innovative work involving the Rhodococcus bacterium. His research focuses on the production of aryl acylamidase, an enzyme with various applications in biochemistry.

Latest Patents

David J Best holds a patent for the production of aryl acylamidase using a specific bacterial strain. The patent details a process that involves culturing an aryl acylamidase-producing bacterial strain selected from Rhodococcus erythropolis NCIB 12273, along with its mutants or variants. This process culminates in the collection of aryl acylamidase-containing material, showcasing his expertise in microbial biotechnology. He has 1 patent to his name.

Career Highlights

David is currently associated with Medisense, Inc., where he continues to explore innovative solutions in the field of biotechnology. His work has not only advanced scientific understanding but also contributed to practical applications in various industries.

Collaborations

David collaborates with Peter A Vaughan, leveraging their combined expertise to drive forward their research initiatives. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

David J Best's contributions to biotechnology, particularly through his patent on aryl acylamidase production, highlight his role as a key innovator in the field. His ongoing work at Medisense, Inc. continues to pave the way for future advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…